Tiger Brokers

  • Quotes
  • Products
    • Cash Boost Account
    • US Stocks
    • US Fractional Shares
    • HK Stocks
    • China A-shares
    • Options
    • Futures
    • US Treasury
    • Auto-invest
    • Fixed Coupon Notes
    • Tiger BOSS Debit Card
    • Fund Mall
    • Tiger Vault
    • Tiger Open Platform
    • Wealth
  • Pricing
    • Prime
      • Stocks & ETFs
      • Options, Warrants & CBBCs
      • Futures
      • Bonds
      • Fund Mall
    • Cash Boost
      • Stocks & ETFs
    • Financing Interest Rates
  • Promotions
  • Help
    • Account Operations
      • How to Open an Account?
      • Account Opening Documents
      • Account Types Available
    • Transfer & Pay
      • Account Funding
      • DDA Fast Deposit
      • Funds Withdrawal
      • Shares Transfer-in
      • Shares Transfer-out
      • Currency Conversion
    • Products & Trading
      • Products Available
      • Order Types
      • Trading Rules
      • Declaration
    • Margin Trading & Short Selling
      • Margin & Leverage
      • Risk Management
      • Short Selling Risk
    • Fund Mall
      • Open a fund account and transaction
    • Cash Boost Account
      • Cash Boost Account FAQ
      • How to Open Cash Boost Account
      • How to Contra Trade using Cash Boost Account
      • How to link your CDP Securities Account
    • Tiger Boss Debit Card
      • Frequently Asked Questions
      • Fees of the Debit card
      • How to Top-up
      • How to use my Debit card
    • Tiger Vault
      • Features of Tiger Vault
      • Transaction Fees
    • Statement
      • Statement
      • Dividends
  • Learn
  • TigerAI
  • Institution
    • Wealth and asset manager
    • Proprietary trading institutions
    • Introducing brokers
    • Third-party service provider
  • Careers
    • L.E.A.P Programme
    • Investment Representative
    • Careers Portal
  • LOGIN
  • SIGN UP
US StockDetailed Quotes
Provided by Tiger Fintech (Singapore) Pte. Ltd.

Pfizer

24.54
-0.3000-1.21%
Post-market: 24.540.00000.00%19:59 EDT
Volume:46.37M
Turnover:1.14B
Market Cap:139.52B
PE:17.74
High:24.95
Open:24.79
Low:24.46
Close:24.84
Loading ...
OverviewCompanyNewsFilings
Nov 16, 2018

Beneficial Ownership Change

[Amend] General statement of acquisition of beneficial ownership
Sep 05, 2018

[Supp]Public Prospectus

Aug 15, 2018

Beneficial Ownership Change

Dec 21, 2017

Major Issues Report

May 26, 2017

Beneficial Ownership Change

辉瑞制药(pfe . n:行情)(申请)
Mar 01, 2017

[Supp]Public Prospectus

Feb 24, 2017

[Supp]Public Prospectus

辉瑞公司
Nov 15, 2016

[Supp]Public Prospectus

Nov 15, 2016

[Supp]Public Prospectus

自由写作招股说明书
Nov 14, 2016

Major Issues Report

Nov 14, 2016

Major Issues Report

宣布收购要约对任何和所有的6.200%高级笔记定于3月15日,2019年
Jun 01, 2016

[Supp]Public Prospectus

May 19, 2016

Correspondence

May 19, 2016

Correspondence

与美国证券交易委员会(SEC)的通信
Apr 13, 2016

Correspondence

Apr 13, 2016

Correspondence

与美国证券交易委员会(SEC)的通信
Apr 05, 2016

Business Combinations

Apr 05, 2016

Business Combinations

Mar 31, 2016

Business Combinations

Mar 30, 2016

Business Combinations

More

Analyst Rate

Hold
Buy
36.00%
Hold
60.00%
Sell
4.00%

Corporate Actions

Ex-dividend Date
May 09, 2025 Dividend Per Share 0.43 USD
Financial Report Announcement
Apr 29, 2025 Pre-Market
Financial Report Announcement
Feb 04, 2025 Pre-Market
Ex-dividend Date
Jan 24, 2025 Dividend Per Share 0.43 USD
Ex-dividend Date
Nov 08, 2024 Dividend Per Share 0.42 USD

Dividend History

Ex-DateDividend
2015-08-050.28
2015-11-040.28
2016-02-030.3
2016-05-110.3
2016-08-030.3

Valuation Analysis

17.92
Current
-10.76
Sector Average
66.10%
Historical Percentile
P/E[TTM]
+1 STD
Average
-1 STD
Current
17.92
Maximum
75.17
+1 STD
105.90
Minimum
-564.28
-1 STD
-127.42
Average
-10.76

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10
     
     
     
     
Company Name:
Tiger Fintech (Singapore) Pte. Ltd.
Email Address:
uservice@ttm.financial
User Agreement|Privacy Policy

Copyright © Tiger Fintech (Singapore) Pte. Ltd.

Product offerings in different jurisdictions may vary.

Information contained on this website is general in nature and does not take into account of your investment objectives, financial situation and specific needs. It should not be regarded as an offer to sell, asolicitation to buy, a recommendation or endorsement for any financial product, nor does it constitute an investment forecast, investment return commitments, investment suggestions or other practical operating opinions. Information contained on this website is for reference only and past performance should not be construed as future performance. Investment involves risks. Before you make an investment decision, you should carefully judge and screen whether the information contained on this website is appropriate for your needs, goals and circumstances.

We strive but cannot guarantee the accuracy, completeness, reliability and timeliness of all information on this website, and we are not responsible for any losses caused by the use of or reliance on relevant information.

The products and services offered on the website are subject to applicable laws, regulations and relevant agreements. Please carefully read and agree to the agreements before using our products and services.